$IOVA
IOVANCE BIOTHERAPEUTICS, INC. Stock $iova

2013 Q4 Form 10-Q Financial Statement

Concept	2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$19.70M
YoY Change
Cash & Equivalents	$19.67M
Short-Term Investments	$0.00
Other Short-Term Assets	$200.0K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$19.85M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$27.76K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$27.76K
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$19.85M
Total Long-Term Assets	$27.76K
Total Assets	$19.87M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$413.0K
YoY Change	-62.46%
Accrued Expenses	$1.518M
YoY Change	-60.05%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.270M
YoY Change	-79.91%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.270M
Total Long-Term Liabilities	$0.00
Total Liabilities	$2.300M
YoY Change	-79.65%
SHAREHOLDERS EQUITY
Retained Earnings	-$64.53M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$17.60M
YoY Change
Total Liabilities & Shareholders Equity	$19.87M
YoY Change

Concept	2013 Q4
OPERATING ACTIVITIES
Net Income	-$11.50M
YoY Change	-431.41%
Depreciation, Depletion And Amortization	$10.00K
YoY Change	0.0%
Cash From Operating Activities	-$2.250M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change
Cash From Investing Activities	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	21.80M
YoY Change
NET CHANGE
Cash From Operating Activities	-2.250M
Cash From Investing Activities	0.000
Cash From Financing Activities	21.80M
Net Change In Cash	19.55M
YoY Change
FREE CASH FLOW
Cash From Operating Activities	-$2.250M
Capital Expenditures	$0.00
Free Cash Flow	-$2.250M
YoY Change

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	18893211	shares